Chronic Inflammation May Enhance Leiomyoma Development by the Involvement of Progenitor Cells

Although the etiology of leiomyoma is unclear, a progenitor/undifferentiated cell population has been described whose dysregulation may be involved in the onset of uterine conditions. Moreover, inflammation is involved in the development of several tumors. The aim of this work was to understand if p...

Full description

Saved in:
Bibliographic Details
Main Authors: Monia Orciani, Miriam Caffarini, Alessandra Biagini, Guendalina Lucarini, Giovanni Delli Carpini, Antonella Berretta, Roberto Di Primio, Andrea Ciavattini
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2018/1716246
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560626210177024
author Monia Orciani
Miriam Caffarini
Alessandra Biagini
Guendalina Lucarini
Giovanni Delli Carpini
Antonella Berretta
Roberto Di Primio
Andrea Ciavattini
author_facet Monia Orciani
Miriam Caffarini
Alessandra Biagini
Guendalina Lucarini
Giovanni Delli Carpini
Antonella Berretta
Roberto Di Primio
Andrea Ciavattini
author_sort Monia Orciani
collection DOAJ
description Although the etiology of leiomyoma is unclear, a progenitor/undifferentiated cell population has been described whose dysregulation may be involved in the onset of uterine conditions. Moreover, inflammation is involved in the development of several tumors. The aim of this work was to understand if progenitor cells sustain a chronic inflammatory microenvironment that enhances leiomyoma development. Cells from 12 human leiomyoma and 12 normal myometrium samples of the same patients were in vitro isolated and exhaustively characterized (morphology, proliferation, cytofluorometry, differentiation, RT-PCR, immunofluorescence, immunohistochemistry, and Western blotting assays). Selected cytokines (ELISA) and inflammation-related genes (RT-PCR) were analyzed to identify healthy myometrium progenitor cells (MPCs) and leiomyoma progenitor cells (LPCs). Results show that (i) MPCs and LPCs share stemness features, such as immunophenotype and multidifferentiation assay, (ii) LPCs have a significantly shorter doubling time and a significantly higher expression of stemness genes (p<0.05), and (iii) LPCs secreted significantly higher levels (p<0.05) of cytokines related to chronic inflammation and significantly lower amounts (p<0.05) of cytokines related to acute inflammation. Despite the limited sample size, comparisons between leiomyoma and normal myometrium tissue from each patient allowed normalization of patient-specific differences. The evidenced cytokine expression pattern related to chronic inflammation in LPCs may play a role in the increased risk of adverse obstetric outcomes (infertility, spontaneous miscarriage, and preterm birth) in women affected by leiomyomas. These women should be recognized as “high risk” and subjected to specialized management both before and during pregnancy.
format Article
id doaj-art-cf422ce5c7304fee8dc54cca03549821
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-cf422ce5c7304fee8dc54cca035498212025-02-03T01:27:09ZengWileyStem Cells International1687-966X1687-96782018-01-01201810.1155/2018/17162461716246Chronic Inflammation May Enhance Leiomyoma Development by the Involvement of Progenitor CellsMonia Orciani0Miriam Caffarini1Alessandra Biagini2Guendalina Lucarini3Giovanni Delli Carpini4Antonella Berretta5Roberto Di Primio6Andrea Ciavattini7Department of Clinical and Molecular Sciences and Histology, Università Politecnica delle Marche, 60126 Ancona, ItalyDepartment of Clinical and Molecular Sciences and Histology, Università Politecnica delle Marche, 60126 Ancona, ItalyDepartment of Clinical Science, Università Politecnica delle Marche, 60126 Ancona, ItalyDepartment of Clinical and Molecular Sciences and Histology, Università Politecnica delle Marche, 60126 Ancona, ItalyDepartment of Clinical Science, Università Politecnica delle Marche, 60126 Ancona, ItalyClinic of Immunology, Azienda Ospedali Riuniti di Ancona, 60126 Ancona, ItalyDepartment of Clinical and Molecular Sciences and Histology, Università Politecnica delle Marche, 60126 Ancona, ItalyDepartment of Clinical Science, Università Politecnica delle Marche, 60126 Ancona, ItalyAlthough the etiology of leiomyoma is unclear, a progenitor/undifferentiated cell population has been described whose dysregulation may be involved in the onset of uterine conditions. Moreover, inflammation is involved in the development of several tumors. The aim of this work was to understand if progenitor cells sustain a chronic inflammatory microenvironment that enhances leiomyoma development. Cells from 12 human leiomyoma and 12 normal myometrium samples of the same patients were in vitro isolated and exhaustively characterized (morphology, proliferation, cytofluorometry, differentiation, RT-PCR, immunofluorescence, immunohistochemistry, and Western blotting assays). Selected cytokines (ELISA) and inflammation-related genes (RT-PCR) were analyzed to identify healthy myometrium progenitor cells (MPCs) and leiomyoma progenitor cells (LPCs). Results show that (i) MPCs and LPCs share stemness features, such as immunophenotype and multidifferentiation assay, (ii) LPCs have a significantly shorter doubling time and a significantly higher expression of stemness genes (p<0.05), and (iii) LPCs secreted significantly higher levels (p<0.05) of cytokines related to chronic inflammation and significantly lower amounts (p<0.05) of cytokines related to acute inflammation. Despite the limited sample size, comparisons between leiomyoma and normal myometrium tissue from each patient allowed normalization of patient-specific differences. The evidenced cytokine expression pattern related to chronic inflammation in LPCs may play a role in the increased risk of adverse obstetric outcomes (infertility, spontaneous miscarriage, and preterm birth) in women affected by leiomyomas. These women should be recognized as “high risk” and subjected to specialized management both before and during pregnancy.http://dx.doi.org/10.1155/2018/1716246
spellingShingle Monia Orciani
Miriam Caffarini
Alessandra Biagini
Guendalina Lucarini
Giovanni Delli Carpini
Antonella Berretta
Roberto Di Primio
Andrea Ciavattini
Chronic Inflammation May Enhance Leiomyoma Development by the Involvement of Progenitor Cells
Stem Cells International
title Chronic Inflammation May Enhance Leiomyoma Development by the Involvement of Progenitor Cells
title_full Chronic Inflammation May Enhance Leiomyoma Development by the Involvement of Progenitor Cells
title_fullStr Chronic Inflammation May Enhance Leiomyoma Development by the Involvement of Progenitor Cells
title_full_unstemmed Chronic Inflammation May Enhance Leiomyoma Development by the Involvement of Progenitor Cells
title_short Chronic Inflammation May Enhance Leiomyoma Development by the Involvement of Progenitor Cells
title_sort chronic inflammation may enhance leiomyoma development by the involvement of progenitor cells
url http://dx.doi.org/10.1155/2018/1716246
work_keys_str_mv AT moniaorciani chronicinflammationmayenhanceleiomyomadevelopmentbytheinvolvementofprogenitorcells
AT miriamcaffarini chronicinflammationmayenhanceleiomyomadevelopmentbytheinvolvementofprogenitorcells
AT alessandrabiagini chronicinflammationmayenhanceleiomyomadevelopmentbytheinvolvementofprogenitorcells
AT guendalinalucarini chronicinflammationmayenhanceleiomyomadevelopmentbytheinvolvementofprogenitorcells
AT giovannidellicarpini chronicinflammationmayenhanceleiomyomadevelopmentbytheinvolvementofprogenitorcells
AT antonellaberretta chronicinflammationmayenhanceleiomyomadevelopmentbytheinvolvementofprogenitorcells
AT robertodiprimio chronicinflammationmayenhanceleiomyomadevelopmentbytheinvolvementofprogenitorcells
AT andreaciavattini chronicinflammationmayenhanceleiomyomadevelopmentbytheinvolvementofprogenitorcells